Weiner on Braun, Joint Drug Agreement
MLBPA executive director remarks on NL MVP's grievance
NEW YORK -- Michael Weiner, executive director of the Major League Baseball Players Association, today issued the following statement regarding Ryan Braun's grievance and baseball's Joint Drug Agreement.
"Our Joint Drug Program stands as strong, as accurate and as reliable as any in sport, both before and after the Braun decision. The breach of confidentiality associated with this matter is unfortunate but, after investigation, we are confident that it was not caused by the Commissioner's Office, the MLBPA or anyone associated in any way with the Program. In all other respects, the appeals process worked as designed; the matter was vigorously contested and the independent and neutral arbitrator issued a decision deserving of respect by both bargaining parties.
"As has happened several times before with other matters, this case has focused the parties' attention on an aspect of our Program that can be improved. After discussions with the Commissioner's Office, we are confident that all collections going forward will follow the parties' agreed-upon rules."
This story was not subject to the approval of Major League Baseball or its clubs.